Jefferies Gives Pfizer “Buy” Rating; Lowers Estimate (PFE)

By
A A A
Share |

Jefferies lowered estimates for biopharmaceutical company, Pfizer Inc.( PFE ), but reiterated a "Buy" rating on the shares Monday.

The firm has given PFE a price target of $27. This price suggests a 10.3% increase over the stock's current price of $24.20. Analysts have lowered the company's price target due to its revenue miss.

Pfizer shares were mostly flat during premarket trading Monday.


The Bottom Line
We have been recommending shares of Pfizer ( PFE ) since Mar.2, when the stock was trading at $21.49. The company has a 3.64% dividend yield, based on Friday's closing stock price of $24.17.

Pfizer Inc.( PFE ) is a "Recommended" dividend stock at this time, holding a Dividend.com DARS™ Rating of 3.5 out of 5 stars.

Be sure to visit our complete recommended list of the Best Dividend Stocks , as well as a detailed explanation of our ratings system here .



The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of The NASDAQ OMX Group, Inc.

Created by Dividend.com


This article appears in: Investing , Stocks

Referenced Stocks: PFE

Dividend.com

Dividend.com

More from Dividend.com:

Related Videos

Stocks

Referenced

87%

Most Active by Volume

33,110,376
  • $113.99 ▲ 1.77%
25,034,179
    $17.98 unch
24,486,872
  • $7.41 ▲ 2.07%
20,864,535
  • $7.39 ▼ 2.76%
18,600,501
  • $8.30 ▼ 0.36%
17,530,211
  • $8.14 ▲ 3.17%
17,299,208
  • $93.79 ▲ 2.74%
14,669,760
  • $25.78 ▼ 0.19%
As of 12/26/2014, 04:15 PM


Find a Credit Card

Select a credit card product by:
Select an offer:
Search
Data Provided by BankRate.com